Cefprozil
33 NDCs across 6 manufacturers|33 Generic,0 Brand
Cefprozil is used to treat bronchitis, escherichia coli infections, haemophilus infections, klebsiella infections, moraxellaceae infections and otitis media, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Dec 23, 1991, and the first generic was approved Nov 14, 2005. FDA's Orange Book lists 14 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $711K on Cefprozil across 26,000 claims for 21,000 beneficiaries.
Cefprozil is available as 33 NDCs from 6 manufacturers (33 generic, 0 brand), with NADAC prices from $0.09 to $0.23 per ML — the most expensive product costs about 2.4× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
33
33G / 0B
Manufacturers
6
competing in market
Price Spread
$0.09 – $0.23
per ML, 19 of 33 NDCs
7d Activity
avg +0.1% WoW · of 33 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Rising Pharma Holdings Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
6 manufacturers producing CEFPROZIL
Frequently Asked Questions
What is Cefprozil used to treat?
Cefprozil is used to treat bronchitis, escherichia coli infections, haemophilus infections, klebsiella infections, moraxellaceae infections and otitis media, per the National Library of Medicine's MED-RT classification.
When did Cefprozil become available as a generic?
FDA approved the first generic Cefprozil (ANDA) on Nov 14, 2005. The Orange Book currently lists 14 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Cefprozil?
In 2024, Medicare Part D spent $711K on Cefprozil across 26,000 claims for 21,000 beneficiaries.
How many Cefprozil products are on the market?
The Cefprozil drug market contains 33 NDCs from 6 manufacturers — 33 generic and 0 brand products.
What is the price range for Cefprozil?
NADAC reference prices for Cefprozil range from $0.0943 to $0.2277 per ML — the most expensive product costs about 2.4× the cheapest. 14 additional products are priced per different units (e.g. liquids per ML) and aren't directly comparable.
Which manufacturers make Cefprozil?
6 manufacturers list Cefprozil in NADAC. Ranked by number of NDCs, the largest are Rising Pharma Holdings Inc. (9), Aurobindo Pharma Limited (7), NorthStar Rx LLC (7), Lupin Pharmaceuticals Inc. (6), Teva Pharmaceuticals USA Inc. (2).
How has the price of Cefprozil changed recently?
Over the past 7 days, 8 Cefprozil NDCs rose and 17 fell, with a market-wide average change of +0.1%.